Group items tagged

Dr. Calvin Stiller, Chair of Ontario Institute for Cancer Research, Co-Founder and Board Member of MaRS Discovery District and past chair of Genome Canada is a recipient for the 2010 Canada Gairdner Award.

Calvin Stiller, chairman of the Ontario Institute for Cancer Research, won the Canada Gairdner Wightman Award for his work on the use of cyclosporine as a treatment for organ transplant rejection, but also for his role as a scientific entrepreneur, and a rainmaker for major scientific projects. Dr. Calvin Stiller is the Chair of Ontario Institute for Cancer Research, Co-Founder and Board Member of MaRS Discovery District and past chair of Genome Canada.

MaRS CEO, Ilse Treurnicht, and Board Member, John Manley, are both interviewed for the Action Canada report. This report recommends a national strategy for "owning the podium" in entrepreneurship.

MaRS Board member Cal Stiller is inducted into the Canadian Medical Hall of fame.

Robert Tweedy a MaRS Advisor has been appointed to the board of directors of Semcan.

Pershing Square Capital Management, L.P. announced that Paul Haggis, one of Canada's most respected business leaders, has agreed to join the Nominees for Management Change. Dr. Anthony R. Melman, 64, is Chairman and Chief Executive Officer of Nevele Inc. Dr Melman is also the Chair of the Board of Directors Dr. Melman pf Cogniciti Inc., a for-profit joint venture created by Baycrest and MaRS Discovery District.

The Long Tail is really about the economics of abundance. New efficiencies in distribution, manufacturing, and marketing are essentially resetting the definition of what's commercially viable across the board. If the 20th century was about hits, the 21st will be equally about niches.

MaRS Innovation announced the appointment of its first full-time president, Raphael (Rafi) Hofstein.

Karl Martin turned a pure research project into a commercial venture set to change how we interact with the emerging "surveillance society" by improving personal privacy. U of T's Innovations and Partnerships Office and the MaRS Centre came on board to help these researchers patent their work and attain funding opportunities.

Canasia Solar Corp., a wholly owned subsidiary of Canasia Power Corp. announced they are pleased to welcome Mr. Tom Rand as Special Advisor to their Board.

Dr. Calvin Stiller, Chair of Ontario Institute for Cancer Research, Board Member of MaRS Discovery District and past chair of Genome Canada is a recipient for the 2010 Canada Gairdner Award.

"CBOC provides information on Canadian economic trends, public policy, and organizational performance. Three important subject matters covered are: Economic Performance Trends: Forecast indicators, Historical indicators, Custom services, Conference information, Dictionaries, and a link to the Canadian Tourism Research Institute. More specifically, the Economic forecast indicators focus on Canadian, Provincial, Metropolitan, and Industrial outlooks, as well as at U.S. forecasts."

"The United States spends more on health care-related research and development than any other country. In 2003, it was estimated that the Federal government alone spent over $26 billion. Pharmaceutical companies, device manufacturers and other private companies invested over $10 billion more. At its best, the American health care system is capable of delivering care unsurpassed anywhere else in the world. Yet, a 1999 Institute of Medicine study estimated that as many as 98,000 Americans die each year from hospital related medical errors. A recent study by the Rand Corporation (a non-profit think tank) concluded that less than 50 percent of encounters with doctors and hospitals resulted in optimal, evidence-based treatment. Studies show that as many as 42 million Americans - almost 15 percent of the population - lack health care insurance. Surveys reveal that patients do not feel they have adequate information about their conditions, and that their experience with health care ranks below that of most other sectors, in fact below that of the post office. In the aggregate, the country is spending nearly $2 trillion on health care, and yet the nation's health care system does not meet acceptable thresholds for safety, quality, access or cost. In 2005, VHA Health Foundation's board of directors sought to better understand the reasons behind this paradox. The foundation commissioned Larry Keeley and his associates at Doblin Inc. to apply the rigorous analytical methods that are used in their evaluation of other American industries and companies. The project set out to discover when, where and how innovation was taking place in health care. It also sought to identify organizations that were developing model innovation processes, and to explore where opportunities for successful innovation might lay."

This Toronto based incorporation brings entrepreneurs, public and private companies, investors, non-profit organizations, academia, professionals, and government to promote the social value of innovation. SEC has an Advisory Board, a large global networking of business partners, a news feed, and a personal business model, to be found at http://www.seconsortium.com. Social individuals with business and management skills are welcomed to join the team.

The ORION Leadership Awards will be presented on April 16th, 2012. The award recognizes innovation leadership in Ontario's e‐Infrastructure, Higher Education, and the K‐12 sectors. In addition ORION will be announcing the THINK conference. Ilse Treurnicht, CEO of MaRS Discovery District will be speaking at the THINK conference.

Ilse Treurnicht, CEO of MaRS Discovery District was one of the speakers at the THINK Conference. "The Honourable Brad Duguid, Ontario's Minister of Economic Development and Innovation, presented the ORION Leadership awards on April 16th to high school student Marshall Zhang, John Helliker of Sheridan College and University of Toronto professor Dr. Shana Kelley." 

Technology innovators will have an opportunity to jump start their ideas with a new accelerator program from MaRS Discovery District. Called JOLT, the program is focused on building high-growth Web and mobile companies in the information, communications and entertainment sectors.

Technology innovators will have an opportunity to jump start their ideas with a new accelerator program from MaRS Discovery District. Called JOLT, the program is focused on building high-growth Web and mobile companies in the information, communications and entertainment sectors.

Why Should I Care event took place on April 16th. Dr. Ilse Treurnicht, CEO of MaRS Discovery District discussed how the development of Phase 2 will help to build tomorrow's knowledge-based economy.

MaRS announced the creation of JOLT, a new technology accelerator dedicated to building high-growth web and mobile companies that promise to transform the way consumers and enterprises connect, work and play. 

Dr Ilse Treurnicht, CEO, MaRS Discovery District discusses Canadian innovation with Amanda Lang and a panel of experts on CBC's The National.